A narrative review of the role of glucocorticoid receptors in prostate cancer: developments in last 5 years

BACKGROUND AND OBJECTIVE: Glucocorticoids, secreted from the adrenal gland, are commonly used in the treatment of castration-resistant prostate cancer (CRPC) because of their anti-inflammatory and anti-toxic effects. However, glucocorticoids have been reported to have the opposite effects within the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Feng, Shi, Yue, Zhao, Guan’an, Aufderklamm, Stefan, Murray, Katie S., Jin, Baiye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459548/
https://www.ncbi.nlm.nih.gov/pubmed/36092840
http://dx.doi.org/10.21037/tau-22-501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459548/
https://www.ncbi.nlm.nih.gov/pubmed/36092840
http://dx.doi.org/10.21037/tau-22-501

Ejemplares similares